The field of geroscience champions modifiable aspects of biological ageing with the aim of enabling healthier old age. The focus is on common mechanisms of ageing, as knowledge of these processes and how they might be modified could potentially impact the management of a broad range of age-related morbidities 1, 2 . This emphasis is in keeping with a major shift in focus by the World Health Organization (WHO) towards promoting better age-related functional health in response to the changing demographics of human society and an anticipated major burden of non-communicable age-related diseases and their associated societal health-care costs. By 2020, estimates suggest that adults aged 60 years and older will outnumber children younger than 5 years of age. By 2050, those older than 60 years will likely outnumber those younger than 14 years and constitute 2 billion people worldwide 3 . The numbers of deaths owing to chronic kidney disease (CKD) and some cancers are increasing globally, whereas other aetiologies, including ischaemic heart disease, cirrhosis, and a range of cancers and dementias, have shown significant declines in-age standardized disability-adjusted life years (DALYs) amid rising total DALYs 4 . These figures reflect the growing impact of natural ageing processes on global age-related decline in renal health.
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The impact of ageing manifests as an increasing burden of 'wear and tear' across the body, whereby the maintenance of physiological homeostasis is impaired and the effects of allostasis become more prevalent. Allostatic load can thus be defined as a composite indicator of accumulated biological stress throughout the life course, which predisposes to morbidity in the face of exposure to chronic or repeated stress 5 . Assessing allostatic load is not straightforward and necessitates an integrative analysis of a series of biomarkers for stress, ageing, and immune function 6 . In addition, such assessment requires an understanding of epigenetic effects that are differentially responsive to environmental changes at different stages in the life course and that can be transmitted across generations 7 . Typically, such epigenetic effects centre on coordinated changes in the expression of genes, mediated by changes in their methylation status and associated chromatin structure, which in turn are effected through, and influenced by, the regulatory activities of noncoding RNAs (ncRNAs). These effects mediate interplay with psychosocial, socioeconomic, nutritional and lifestyle factors that affect healthspan 8, 9 . These environmental factors are, however, often neglected or overlooked in favour of mechanistic approaches to understand renal ageing and pathology.
In this Review, we describe the ageing process and the epigenetic regulation of signalling pathways that modulate natural ageing. We discuss how these processes are altered in progeric diseases and how they impact on renal disease. In particular, we highlight the interplay of epigenetic signalling pathways with environmental factors, such as psychosocial, lifestyle and nutrition mediators of ill health in the context of renal biology, and discuss how the epigenetics of ageing might be modified to treat age-related morbidities.
Ageing and renal dysfunction
Distinguishing normal features of the ageing process from age-related dysfunction is critical to enable understanding of age-related organ health. This point is pertinent to a range of morbidities 1 , but is particularly relevant in the context of CKD. The incidence of CKD is ~10-12% in the developed world and is growing 10 . Notably, CKD incidence increases with chronological age and almost 50% of patients with end-stage renal disease (ESRD) are aged 65 years or older. Heterogeneity seems to exist in the processes that lead to CKD and factors beyond chronological age, such as epigenetic alterations, are likely to contribute to a decline in renal function during ageing 1 . Accelerated cellular and physiological ageing are underlying components of a number of morbidities, including CKD 1, [11] [12] [13] . Correspondingly, patients with CKD show a higher incidence of mortality in comparison to healthy chronologically age-matched individuals, indicative of systemic differences layered on top of the dysregulated ageing process (FIG. 1) . As the prevalence of CKD parallels an increased prevalence of type 2 diabetes mellitus, obesity and a sedentary lifestyle 14 , an allostatic outcome reflecting the 'burden of lifestyle' might be present in addition to the effects of CKD per se. As lifestyle factors directly affect the epigenome 15 , the effects of epigenetic changes on premature biological ageing and renal dysfunction merit interest.
Loss of plasticity and/or resilience to adaptions to the changing internal uraemic environment promote vascular ageing processes and result in a marked discrepancy between chronological and biological age in patients with CKD 1 . As the kidney ages chronologically, a range of functional and structural changes occur commensurate with a decrease in glomerular filtration rate, altered sodium regulation, increased renin-angiotensin activity, nephron loss, tubular atrophy, diverticula formation, decreased tubular number, interstitial fibrosis and thickening of the glomerular basement membrane. Parenchymal calcification and renal arterial atherosclerosis are also observed 1, 16 . In addition, the uraemic pheno type is characterized by many features that typically characterize the aged population, such as frailty, depression, cognitive dysfunction, sexual dysfunction, hypogonadism, inflammation, gut dysbiosis, proteinenergy wasting, osteoporosis and premature vascular ageing, including atherosclerosis (media thickening) and arteriosclerosis (media calcification) 1, 17, 18 . In mammals, ageing is associated with an accumulation of senescent cells, which are characterized by the expression of cyclin-dependent kinase inhibitor 2A (CDKN2A, also known as p16INK4a), cellular growth arrest and a distinct epigenotype. Accumulation of these cells is associated with loss of functional capacity in organs such as the kidney 16, 19 . Changes in NF-κB expression are also typical and result in a proinflammatory senescence-associated secretory phenotype (SASP), which enables paracrine-mediated signalling to adjacent tissues (bystander effects) [19] [20] [21] . This mechanism might spread allostatic load via secretion of SASP factors and extracellular secretory vesicles into the circulation 20, 21 . Knock-on effects include loss of regenerative capacity and a decrease in the availability of nitric oxide 22 . As the cardiovascular system is vulnerable to the uraemic milieu, CKD represents a segmental progeroid syndrome 23 . Understanding the nature of premature ageing mechanisms in the perturbed uraemic milieu might, therefore, enable the rational development of prophylactic interventions, as well as novel targeted treatment strategies for renal dysfunction (FIG. 1) .
Biomarkers of ageing
Increasing chronological age results in a loss of physical capability and function, but substantial variation exists among people of the same chronological age owing to a host of environmental, genetic and epigenetic contributors. Thus, no gold standard exists for determining what constitutes normal ageing. Biomarkers of ageing should, therefore, be markers of health-related function that show a significant association with chronological age in the absence of disease 24, 25 . Over the past 50 years a number of candidate biomarkers of ageing have been developed, but all have proven insufficiently robust. For example, systematic reviews of the evidence relating telomere length to mortality and/or lifespan and to normal age-related decline in health measures found few mortality studies, all of which suffered from survivor bias 8, [26] [27] [28] . Few studies have examined the relationship between telomere length and age-related functional decline, and those that have were equivocal and all lacked statistical power 9, 29 . Longitudinal analyses of renal allografts, acting as a source of healthy tissue and yielding eGFR as a
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Epigenetic clock
A biological clock based on the levels of DNA methylation at a number of defined loci that is used to estimate the biological age of a tissue, cell type, organ or individual.
Epigenetic drift
Age-associated divergence of the epigenome owing to stochastic alteration of DNA methylation.
functional measure of health, have supported the use of CDKN2A expression as a validated biomarker of ageing 11, 30, 31 . This finding led to the identification of a microRNA (miRNA)-based epigenetic signature associated with regulation of the CDKN2 locus that similarly fulfils the criteria for a biomarker of ageing and importantly, is active in ageing-related biochemical pathways that are conserved across taxa, including the mTOR and PI3K-AKT pathways 32 . As these pathways are involved in the regulation of chromatin modifiers, notably sirtuin family members, they link nutrient sensing, cellular metabolism and stress defences to age-related renal function 32 . The activities of the mi RNAs in the epigenetic signature (mi RNA-125a-5p, miRNA-125b, miRNA-96 and miRNA-217), therefore, relate to the nine hallmarks of ageing (genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, and altered intercellular communication) 33 , that represent common denominators of ageing in different organisms. In addition, a number of these mi RNAs, which are discussed in more detail below, are epigenetically regulated by DNA methylation in keeping with the activities of an epigenetic clock 34 .
Epigenetics
The term epigenetic denotes heritable changes in gene expression that do not involve changes in the underlying DNA sequence; that is, a change in phenotype without a change in genotype. Epigenetic regulation facilitates biological plasticity in response to environmental changes and enables transgenerational transmission of such responses. Addressing age-related changes in epigenetic plasticity is challenging, as changes in chromatin, metabolic networks and tissue structure and function seem to underpin a range of age-related diseases 35, 36 . Two distinct forms of epigenetic inheritance can be described, comprising those that engender an intergenerational effect and those that engender a transgenerational effect. An intergenerational epigenetic effect can be induced during development by the intrauterine environment, thus transmitting the effect from one generation to the next 37 . By contrast, transgenerational epigenetic inheritance occurs when developmental programming can be transmitted across generations that were not subject to the initial environment stimulus that triggered the epigenetic change 37 (FIG. 2) . Little is known about the role of epigenetic inheritance in kidney disease.
Methylation
Classically, loss of genomic methylation and associated heterochromatin has been considered a feature of the ageing cellular genome 38 . Levels of genomic methylation display age-related epigenetic drift that may directly affect ageing processes 39 . Age-related changes in patterns of genomic DNA methylation have also been formulated as an epigenetic clock. These changes show excellent correlation with chronological age 34, 40, 41 , but strong correlations with biological age (that is, age-related biological function) remain to be proven. Despite this limitation, clear evidence indicates that changes in the methylome incorporated into epigenetic clocks are predictive of allcause mortality even after adjusting for chronological age and a variety of known risk factors [42] [43] [44] . Methylome-based epigenetic age has been associated with longevity, frailty and both cognitive and physical fitness 45, 46 and has been used to demonstrate accelerated ageing in a range of conditions, including diverse neurodegenerative conditions (Parkinson disease, Alzheimer disease-related neuropathologies), lung cancer, lifetime stress, menopausal age, obesity, metabolic syndrome, coronary heart disease and renal disease 45 . Furthermore, methylome-based epigenetic age has been shown to reflect accelerated ageing associated with environmental stressors, such as poor diet, lack of exercise and chronic low-grade inflammation 46 . Figure 1 | The epigenetic landscape mediates the interplay between stressors and renal dysfunction. Both exogenous (environmental) and endogenous (physiological) stimuli lead to changes in the epigenetic landscape that impact renal ageing and physiology. These changes reflect accumulating allostatic load, both physiologically across the body and at the cellular and molecular levels. The resulting functional changes in cellular biology that reflect accelerated ageing processes in the organ act in concert with stress-driven physiological changes to induce further dysfunction that predisposes to and contributes to the progression of disease processes, which may further perturb all the tiers of the epigenome. lncRNA, long non-coding RNA; miRNA, microRNA; piRNA, piwi-interacting RNA; siRNA, small interfering RNA. Nature Reviews | Nephrology 
Metabolic memory
An epigenetic effect that results in the persistence of poor metabolic control after an episode of hyperglycaemia despite a return to normal glycaemic control.
Mitochondrial DNA methylation at two CpG sites (M1215 and M1313) located within the 12S ribosomal RNA gene correlate inversely with chronological age and thus may provide additional epigenetic markers of ageing and function when combined with markers of genomic DNA methylation 47 . As a number of genomewide association studies have not found a correlation between genomic DNA methylation and altered agerelated gene expression 48, 49 , the incorporation of mitochondrial DNA methylation in existing epigenetic clocks might help to remove any equivocation in associations with age-related functional parameters of health.
A number of clinical observations and rodent model studies have indicated that changes in the methylome are implicit in the development and progression of CKD 50 . For example, intrauterine malnutrition has been associated with reduced nephron number 51 and the development of renal disease 52 . Moreover, rodent studies have demonstrated that renal fibrosis is associated with DNA methylation changes that can be mitigated by reducing the expression of DNA ( cytosine-5)-methyltransferase 1 (Dnmt1) 53 . How such changes relate to, or interact with, the ageing process per se, remains to be determined. Such changes do not, however, seem to be associated with renal pathology in CKD 53 . Notably, they provide a platform for the development of metabolic memory, particularly in the context of diabetic nephropathy 54, 55 .
Chromatin structure
Chromatin is a transcriptionally inactive complex of DNA, histone proteins and RNA that packages and epigenetically regulates the functions of DNA within the nucleus by controlling access to genetic regulatory elements. Chromatin forms through packing of DNA around nucleosomes in a number of distinct 3D tiers, enabling assembly of higher order structures that interact directly with the nuclear envelope and link otherwise distal genomic regions 19, 56 . The structure of chromatin changes with age, typified by loss of bound heterochromatin protein 1 and trimethylation of histone H3 on lysine 9 (REF. 57 ). These changes are also observed in human progeric syndromes, such as Hutchinson Guilford Progeria syndrome (HGPS) 58, 59 and Werner syndrome 60 .
Noncoding RNAs
NcRNAs are critical mediators of epigenetic plasticity within cells and organisms that affect and coordinate the regulation of a complex range of molecular processes in response to environmental changes. The ageing Epigenomic changes enable heritable genomic plasticity in response to environmental stressors. Exposure to a range of diverse stimuli can generate epigenomic changes in somatic cells (resulting in intergenerational effects) or germline cells (resulting in transgenerational effects) during prenatal development; these changes influence health outcomes in later life. Stimuli can also have gender-specific effects (not shown). For example, dichlorodiphenyltrichloroethane (DDT) affects fertility in both genders, but has a specific effect on the kidney in males, resulting in a decrease in kidney size in murine models 171, 172 . Multigenerational exposure to an initial stimulus and a subsequent intergenerational effect is not observed beyond the F2 generation. By contrast, transgenerational inheritance has a permanent phenotypic effect in the F3 generation and beyond. This concept is not well documented in humans owing to the complex physiology and complexity of maternal effects during and after gestation (intergenerational effects). miRNA, microRNA; piRNA, piwi-interacting RNA; siRNA, small interfering RNA. 
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Archetypal mi RNAs
Reference miRNA sequences listed in miRNA databases.
process is dramatically influenced by ncRNA activity [61] [62] [63] . A number of distinct classes of ncRNA have been identified, mainly comprising miRNA and long (>200 nucleotides) ncRNAs (lncRNAs). LncRNAs, mi RNAs and their target transcripts form epigenetic regulatory circuits that reciprocally regulate gene expression. These circuits include regulatory interactions with DNA methylation, histone modification, DNMTs and chromatin 64 .
Long noncoding RNAs. LncRNAs regulate gene expression at the transcriptional, post-transcriptional and post-translational levels. They display tissue-specific gene expression 65, 66 and are thought to have direct roles in the ageing process. Putative roles for lncRNAs have also been identified in conditions such as heart failure, cardiac autophagy, hypertension, acute kidney injury, glomerular disease, acute allograft rejection and renal cell carcinoma 66 . The lncRNAs telomerase RNA component (TERC) and telomeric repeat-containing RNA (TERRA) regulate telomere length during cellular ageing 63 . Accelerated telomere erosion is a feature of accelerated ageing in CKD 1 . The involvement of TERRA and/or TERC in this process is intuitive, though this involvement remains to be formally demonstrated. Congruent with miRNA regulation of cellular stress and metabolism in ageing, regulation of Igf2, which encodes insulin-like growth factor 2 (IGF2), involves lncRNA H19 regulation of methyl-CpG-binding domain protein 1 . Interestingly, alterations in H19 expression in the kidneys of embryos carried by hyperglycaemic mice might provide a conduit for an in utero transgenerational transmission of predisposition to renal dysfunction 66 . Also pertinent to renal dysfunction, the lncRNA Tug1 has been demonstrated to regulate mitochondrial function in podocytes 70 . Overexpression of Tug1 improved mitochondrial bioenergetics (which shows age-related dysfunction in a wide range of species) and features of nephropathy in diabetic mice. Analysis of the mech anism underlying these effects showed that Tug1 binding enhances the activity of peroxisome proliferator-activated receptor γ co-activator α (PGC-1α); of note, reduced PGC-1α activity is a feature of end-stage renal disease.
As mentioned above, CDKN2A expression is increased in dysfunctional organs and is a significant determinant of age-related renal function 11, 30, 31 . The antisense ncRNA ANRIL, which is encoded by the INK4 locus, is thought to function as a transcriptional repressor of CDKN2A through interaction with chromobox protein homologue 7 (CBX7) and polycomb protein SUZ12, which are components of polycomb repression complexes 1 and 2, respectively [71] [72] [73] . These complexes modify local chromatin status. ANRIL facilitates recruitment of CBX7 to the CDKN2A locus and the resultant increase in H3K27 methylation epigenetically represses transcription of CDKN2A 72, 74 .
MicroRNAs. miRNAs comprise an evolutionary conserved group of ubiquitously expressed single-stranded 20-24 nucleotide RNAs that act as negative posttranscriptional regulators, either via RNA silencing or translational inhibition 75, 76 . They can show tissuespecific expression and are subject to epigenetic regulation by differential methylation and chromatin changes. In humans, 1,881 functional mi RNAs have been characterized and are thought to target ~60% of protein coding genes 77, 78 . However, over 4,000 putative candidate mi RNAs have been identified by sequence searches 79 . Isoforms of archetypal mi RNAs (isomiRNAs) with different 5 prime and/or 3 prime termini generated from the same pre-miRNA have also been identified. Some of these isomiRNAs are substantially more abundant than the archetype miRNA 80 . Knowledge of isomiRNA targets, functions and their involvement in disease processes remains sparse.
Conversely, knowledge of archetype mi RNAs and their role in the kidney is abundant. These mi RNAs have been implicated in renal physiology, development and pathology 66, [81] [82] [83] [84] [85] . The interactions of mi RNAs identified as important for age-related renal function indicates that they facilitate the maintenance of an intracellular regulatory network consistent with the mitochondrion/telomere nucleoprotein complex/ribosome (MTR) postulate 86 in which intracellular energy availability determines the capacity of a cell for proteosynthesis in response to macro molecular damage and/or redox stress, and nutrient availability and utilization via mTOR 86, 87 . This role is consistent with the finding that interventions that promote healthspan and longevity, such as calorie restriction and administration of rapamycin, act directly through effects on the mTOR pathway 88, 89 .
Epigenetics and progeria
Examination of the pathology of accelerated ageing syndromes with elements of renal dysfunction, such as HGPS, can aid understanding of how the epigenetics of ageing impacts renal biology. HGPS is a monogenetic disorder caused by mutations in LMNA 90, 91 that recapitulates the cellular and molecular characteristics of physiological ageing and shows wide changes in the epigenetic landscape.
HGPS and physiological ageing have similar cellular (abnormal nuclear morphology, global genomic hypomethylation and increased DNA damage) and tissue pathology (loss of subcutaneous fat, loss of hair, reduced bone mineral density and cardiovascular disease) 92 . In HGPS, accumulation of progerin -a truncated form of lamin A -is associated with alterations in chromatin structure, including a progressive loss of heterochromatin, perturbation of the methylome and impaired genome stability [93] [94] [95] . Interestingly, low levels of progerin have been found in the skin and arteries of individuals without HGPS and these levels increase with age as a result of mutational events 96, 97 , suggesting a role of lamin A in healthy ageing.
Progerin expression is also induced by senescence and telomere damage 98 , which are features of renal ageing and dysfunction 99 . Upregulation of SASP factors and increased staining frequency of senescence-associated β-galactosidase have been shown in mouse models of HGPS 100 . Nuclear lamina defects owing to incorporation of progerin into the nuclear membrane lead to activation of NF-κB signalling so result in systemic inflammation, which is a key feature of both the progeric and uraemic phenotypes 101, 102 . HGPS and uraemia also have similar vascular phenotypes characterized by calcification and increased arterial stiffness 1 . Other non-communicable diseases, such as chronic obstructive pulmonary disease, chronic heart failure and rheumatoid arthritis, might generate similar ageing effects 1 but this hypothesis merits further investigation and testing. An additional feature of HGPS is hyperphosphataemia, which is indicative of reduced renal function and is a common complication of CKD. In the general population hyperphosphataemia is linked directly to nutrition and might increase allostatic load as discussed below 1 . Similar to HGPS, mutations in Klotho lead to progeria with concomitant hyperphosphataemia 103 . Klotho acts as a co-receptor for fibroblast growth factor 23 (FGF-23), which has a critical role in the maintenance of phosphate and vitamin D homeostasis 103 . FGF-23 also has a role in bone mineralization and has been implicated in the impairment of cardiac volume homeostasis in CKD 102 . In the setting of CKD, phosphate retention and decreased renal 1,25(OH)2D3 production lead to chronic increases in the levels of both FGF-23 and parathyroid hormone, resulting in vascular calcification [104] [105] [106] [107] . Klotho-deficient mice show features of progeria 108 , including infertility, vascular calcification, atherosclerosis, organ atrophy, osteoporosis, peripheral insulin sensitivity, metabolic dysfunction and cognitive changes. Moreover, polymorphisms in the gene that encodes klotho have been associated with human ageing and healthspan 109 . Klotho has been shown to protect endothelial cells from senescence by stabilizing the NF-κB/IKK complex, which inhibits translocation of NF-κB from the cytoplasm to the nucleus 110 . Uraemic toxins such as indoxyl sulfate induce hypermethylation of the Klotho gene 111 , possibly mediated through oxidative stress and induction of proinflammatory transcription factors such as NF-κB (REF. 112 ). A reduction in Klotho expression might, therefore, not only result in cellular senescence, but also inhibit an important negative feedback loop resulting in increased inflammation.
Epigenetics and inflammation
Inflammation has an important role in the pathogenesis of premature ageing in a range of morbidities, including CKD, and at different system levels, from epigenetics to the macroscopic phenotype 113 . Many age-related morbidities present with an underlying component of low-grade inflammation of undetermined aetiology. The term 'inflammageing' has been used to describe chronic, low-grade inflammation, which is a risk factor for morbidity and mortality in the elderly population 114 . Similarities exist between inflammation in renal dysfunction and 'inflammageing' in the general population, including upregulation of proinflammatory cytokines, altered immune cell function and telomere attrition 1, 115, 116 . Persistent inflammation in CKD is, however, associated with DNA hypermethylation and telomere shortening 99 , whereas DNA hypomethylation is more typical of accelerated ageing 46 . Thus, observations of hypermethylation in CKD merit further study as they may reflect a distinct epigenetic feature of CKD pathology that is decoupled from natural ageing processes. Inflammation directly affects the activity of enzymes involved in the establishment, maintenance and change of epigenetic landscape across the lifecourse 117, 118 . In CKD associations exist between inflammatory biomarkers such as IL-6, which impairs DNMT activity, and DNA methylation 115 . This finding suggests that inflammation might lead to changes in methylation dynamics that could result in or predispose to subsequent ill health.
An example of renal dysfunction linked to methylation status involves homocysteine, which is critical for DNA methylation, nucleotide biosynthesis and maintenance of genomic integrity 119, 120 . In CKD, circulating homocysteine levels are elevated, enabling its conversion to S-adenosylhomocysteine (SAH). SAH is a competitive inhibitor of methyltransferases and thus has a direct effect on the cellular methylome 121 . Evidence exists of a link between immunosuppressive therapy, ageing and homocysteine biochemistry in renal transplant recipients 122 . As patients with CKD show advanced biological age, normalization of the uraemic milieu after transplantation might be expected to reduce their rate of biological ageing. Despite normalization of the uraemic milieu, however, renal transplant recipients receiving myco phenolate mofetil (MMF) showed continuous acceleration in biological ageing in comparison to patients still on dialysis, suggesting a pro-ageing effect of MMF. Moreover, transplant recipients who received MMF showed a significantly greater degree of telomere attrition than those who received azathioprine, indicating a greater degree of biological ageing. Both transplant groups had higher levels of the methyl donor folate and lower homocysteine levels than patients on dialysis, and those who received azathio prine had lower folate levels than those on MMF. An effect of changes in homocysteine levels on the cellular methylome in patients with CKD and transplant recipients seems intuitive, but further investi gation is required to determine if changes in the status of the methylome either drive or are a consequence of accelerated ageing or clinical interventions 122 . At a cellular level, the SASP might have an important role in the pathogenesis of inflammageing. Senescent cells are proinflammatory 123, 124 and SASP generation seems to be under strong epigenetic control. For example, the histone deacetylase sirtuin 1 might prevent gene expression of proinflammatory transcription factors, such as NF-kB, as well as transcription of proinflammatory cytokines, such as IL-6, which have an important role in the conversion of cells to a SASP-producing cytotype 125 . In addition, the Jumonji D3 histone demethylase JMJD3 can induce both inflammation and senescence 126 . These findings are of potential importance as sirtuin 1 can be targeted using pharmacological interventions (such as resveratrol), whereas JMJD3 can be selectively inhibited using the small-molecule inhibitor GSK-J4 (REF. 127 ). These interventions have not yet been tested in patients with CKD, but resveratrol has been shown to reduce vascular calcification and improve aerobic capacity in uraemic mice 128 .
Imprinted gene
A gene that is expressed in a manner that is epigenetically determined by the sex of the parent who contributed the gene, typically through methylation-based gene silencing.
Environmental factors
Exactly how environmental factors lead to the molecular pathophysiological changes that are associated with ageing and disease, and how these factors might induce heritable transgenerational physiological changes, is not yet clear. A wealth of emerging information on psycho social drivers of age-related health indicates that the early years of life are a key period for establishing their effects 8, 129, 130 . This paradigm is encapsulated within the hypothesis of developmental origins of health and disease 131 , which states that stressors in early life and throughout the life-course, acting cumulatively, interactively or independently, might lead to individual differences in healthspan. Allostatic load can therefore integrate a number of overlapping bio-psychosocial frameworks (that is, interactions between biological, psycho logical, and social factors that determine the cause, manifestation, and outcome of health or ill health) that have been formulated to explain these differences 7, 132, 133 . We hypothesize that how and when any pathology manifests in the kidney is influenced by interindividual differences in a range of factors that affect the epigenetic landscape (FIGS 1,3) . These factors include genetics, lifestyle factors, psychosocial factors and nutrition 134 . In particular, it is intuitive that such interindividual differences will affect organ dysfunction, rate of disease progression, and the type, timing and severity of associated comorbidities. Research into the relationship between individual risk factors and epigenetic alterations relevant for kidney disease is limited. However, a genome-wide association study identified an association between CKD progression and SNPs in LINC00923, a lncRNA expressed in the kidney 135 . The findings of a meta-analysis that investigated the effects of adversity in early life (such as abuse, neglect, low socioeconomic status) on biological ageing (determined by telomere length) support the hypothesis that early adversity has long-lasting physiological consequences that contribute to disease risk, biological ageing and diseases of ageing 136 . Notably, both the type and timing of early adversity significantly impacted the association with telomere length. This finding has been paralleled by studies in rodents, which showed that intrauterine exposure to maternal stress alters telomere length in the brain of adult offspring 137 . Studies in model organisms have also indicated that nutrition has transgenerational epigenetic effects 38 . In humans, the majority of evidence for these effects comes from two cohort studies: the Dutch birth famine and Överkalix studies 134 . Data from the Dutch birth famine cohort indicate transgenerational transmission of effects, including increased neonatal adiposity, type 2 diabetes mellitus and cardiovascular disease 138, 139 . A critical observation was that prenatal famine is associated with hypomethylation of the imprinted gene IGF2, which contributes to insulin resistance 140, 141 . Interestingly, IGF2 transcription is regulated by mi RNA-125b, mi RNA-let 7a and mi RNA-483, which have been implicated in the control of age-related renal function 32 . Notably, mi RNA-125a−5p, mi RNA-125b, mi RNA-96 and mi RNA-217 are associated with age-related renal healthspan and all regulate sirtuin targets 32 . The expression levels of these biomarkers may provide a platform for a molecular quantification of allostatic load linked to physiological function at a given point in the life course. . Epigenomic changes in normal ageing parallel those seen in accelerated ageing in CKD. These changes reflect epigenetic responses to exogenous and endogenous stimuli and nutrient availability throughout the life course concomitant with increasing allostatic load. Epigenetic responses constitute changes in a dynamic series of inter-related regulatory networks that link chromatin dynamics with the methylome, microtranscriptome, transcriptome and proteome. This network is dysregulated and impaired by a range of stressors, including the senescence-associated secretory phenotype (SASP) and calciprotein particle toxicity, resulting in further epigenetic changes, impaired immune and antiageing defences and metabolic dysfunction. ER, endoplasmic reticulum. ncRNA, non-coding RNA. Nature Reviews | Nephrology 
Methyl-donor nutrient
Dietary methyl groups derived from foods that contain methionine, one-carbon units and choline (or the choline metabolite betaine).
Metastable epialleles
Genomic regions in which DNA methylation is established stochastically during embryogenesis and then maintained stably in differentiated cells and tissues, leading to inter-individual epigenetic variation.
Interindividual differences in genomic methylation have also been observed in relation to methyl-donor nutrient intake by mothers of children born during periods of good or poor food availability, indicating that maternal nutrition during early pregnancy causes persistent and systemic epigenetic changes at human metastable epialleles. Levels of DNA methylation were higher in children conceived in food-limited periods (rainy season) than in those conceived in food-rich periods (harvest season). DNA methylation during these periods was influenced by peri-conceptional levels of key micronutrients involved in one-carbon metabolism, which are critical for DNA methylation processes. Children born during a time of poor food availability, which corresponded to high maternal methyl-donor nutrient intake peri-conception, showed increased methylation of six metastable alleles compared with children born during times of good food availability 142 . The finding that folate levels in renal transplant recipients are affected by the use of certain immunosuppressive drugs and are associated with differences in biological age post-transplantation 122 suggests that methyl donor availability is also directly pertinent to renal allograft function and biological ageing.
Genomic hypomethylation and telomere attrition, both features of advanced biological ageing, have been observed in socioeconomically deprived individuals in the general population 143, 144 . These features correlated with chronic inflammation, a greater burden of morbidity and earlier mortality. Notably, telomere attrition is also independently associated with hyperphosphataemia owing to frequent consumption of red and processed meat 145 . These findings suggest that diet-related hyperphosphat aemia associated with low socioeconomic status and poor eating habits might contribute to the increasing incidence of CKD among socioeconomically disadvantaged populations worldwide. Direct evidence for an effect of dietary phosphate on the human epigenome is sparse. However, in human coronary endothelial cells, inorganic phosphate has been shown to induce endothelial-mesenchymal transition via a mechanism involving an altered DNMT1-histone deacetylase 2 interaction and aberrant methylation of the RASAL1 promoter; this mechanism could potentially contribute to endothelial dysfunction in vivo 146 .
Ageing, epigenetics and the microbiome The contribution of the microbiome to human healthspan in relation to diet, environment, inflammatory status and diseases of ageing is an emerging area of research. In particular, the chronic low-grade, systemic inflammation that is associated with ageing, and the progression of senescence in the immune system that contributes to the development of age-related disease, might have microbial components. The effect of the gut microbiota on renal function is beyond the scope of this Review and has been covered in depth elsewhere 147 . The microbial metabolite trimethylamine N-oxide (TMAO) is central to the inter-relationship between gut microbiota, inflammation and the age-related renal epigenome. This proatherogenic and pro inflammatory compound is derived from microbial metabolism of phosphatidylcholine, l-carnitine and lecithin, which are found in red meat, fish and eggs, so provides a mechanistic link between excess red meat consumption, hyperphosphataemia and accelerated ageing 145, 148, 149 . TMAO is also found at increased levels and is an independent predictor of mortality in patients with advanced CKD 150 . In a number of epidemiological studies, less than 25% of interindividual variation in inflammatory status could be explained by associations with biological age 143 or methylation levels 151 , suggesting that the microbiome might have a larger impact on inflammation than anticipated based on the hypoth esis of a linear relationship between biological age and SASP-related inflammatory status.
Translocation of gut microbiota and/or endotoxins into the circulation via disruption or leakage at colonic epithelial tight junctions as a result of altered occludin and claudin expression might also contribute to the burden of systemic inflammation 152, 153 . Dysfunction of tight junction proteins reportedly results in reduced expression of nuclear factor erythroid 2-related factor 2 (Nrf2), a regulator of antioxidant defence genes, thus elevating levels of oxidative stress 113, 153 . Elevated levels of microbial endotoxins have been detected in the circulation of patients with uraemia and have been implicated in the generation of a proinflammatory environment 154 . These processes lead to an increase in inflammation that has a direct inhibitory effect on DNMTs and histone modifiers, with consequential effects on the epigenome. These findings suggest that the type and calibre of nutrition across the life course might have a substantial impact on the accrual of allostatic load. Further investigation of the effect of the microbiota on the epigenome in the uraemic environment is warranted.
Modifying the epigenome in ageing
Although the field remains immature with regard to effects in the kidney, a range of evidence from model organisms through to humans indicates that nutrition, exercise and psychosocial interventions can mitigate the effects of ageing [155] [156] [157] [158] . Encouragingly, such interventions target pathways that are important in the epigenetic regulation of age-related renal function 1, 23 , including the nutrient sensing 5-AMP-activated protein kinase (AMPK) and mTOR pathways. Metformin and rapamycin target AMPK and mTOR, respectively, resulting in slowing of cellular ageing and a reduction in the generation of proinflammatory SASP [159] [160] [161] . Bromodomain-containing protein 4, which binds to acetylated lysines on histones, is also able to inhibit generation of a SASP in murine models, but this effect comes at the expense of impaired immune surveillance 162 . Modulation of sirtuin biochemistry and insulin/IGF signalling can also impact healthspan 19, 88, 158, 160, 161 . Loss of or decline in sirtuin activity with age might facilitate age-associated changes in the epigenome and associated transcriptional profiles. Animal studies have indicated that loss of function of individual sirtuin family members can have dramatic effects on chromatin regulation and lead to progeria and a diverse range of age-associated pathologies 87 . Moreover, the renal ageing mi RNAs 125a-5p, 125b,
Antagonistic pleiotropy
A genetic effect that controls for at least one trait that is beneficial to and at least one trait that is detrimental to the fitness of the organism.
Segmental ageing
Variability in the age of onset and the rate of development of accelerated ageing characteristics in different tissues and organs.
96 and 217, all regulate sirtuin targets and also have roles in the mTOR and PI3K pathways, which along with sirtuins are involved in regulation of inflammation, cellular stress responses and autophagy in response to caloric restriction and exercise 32 . Epigenetic changes induced by calorie restriction ameliorate age-related alterations in methylation in rodent kidneys, suggesting that these epigenetic changes might underlie the beneficial effects of calorie restriction on healthspan 163 . Targeting the cellular methylome is also a promising strategy and various chromatin remodelling agents are in development for preclinical and clinical testing. A number of studies in model organisms have indicated a functional relationship between differential DNA methy lation, transcriptomic effects and the development of age-related renal pathology 139, 140 . This relationship is of particular interest as methylation-based epigenetic changes in CKD models have been associated with high serum phosphate levels 141, 164 . Interventions such as synergistic removal of calciprotein particles might help to mitigate the adverse effects of hyperphosphataemia on the epigenome.
Pertinent in the context of uraemia is modulation of Klotho methylation, possibly in combination with dietary interventions to reduce phosphate intake. Klotho promoter methylation is a feature of CKD 165 . In murine models, treatment with Rhein (an anthraquinone compound used to treat diabetic nephropathy) reverses Klotho methylation 88, 89 . Rhein has various renoprotective functions and effectively corrects DNMT1/DNMT3a-induced Klotho hypermethylation 166 . Additional approaches that target modifications of the epigenetic landscape include cellular reprogramming via miRNA delivery to enhance renal repair, which has shown promise in preclinical models 19, 159 . In addition, senotherapeutics -agents that can remove aged cells -are in development and undergoing preclinical testing, but their impact on the epigenome remains to be established 167 . The potential of this approach was elegantly demonstrated in a study that showed that selective removal of senescent cells by targeted apoptosis using a FOXO4 peptide restored tissue homeostasis and renal function in naturally aged mice 168 . The epigenetics of ageing is clearly important for healthspan and is likely context-dependent. Consequently, approaches to remodel the epigenome need to be investigated across the life course to determine if their effects are uniform, reversible over time or potentially harmful owing to antagonistic pleiotropy. For example, cellular senescence is a key component of organ and tissue ageing that is undesirable early in the life course, but is desirable to prevent cancers later in life. This concept suggests that epigenetic processes associated with senescence might also be subject to context-dependent intervention. Such context-dependence might explain why attempts to functionally reprogramme neurons from aged individuals have resulted in cells that have a rejuvenated transcriptional profile but retain some age-related characteristics 169 . How changes observed in epigenetic regulation of ageing processes across the body can be reconciled with differences owing to segmental ageing and/or tissue or organ-specific disease processes, remains to be resolved. Caution must, therefore, be used in interpretation of any initial successes with agents that target the epi genome, especially when directly extrapolating information derived from model organisms to clinical use. For example, the transgenerational effects resulting from use of the endocrine disruptor vinclozolin in pregnant rats did not emerge until the F1-F4 generations; male offspring showed altered epigenetic programming of the germ line and increased rates of kidney disease, immune system dysfunction, prostate disease, hypercholesterolaemia and cancer 170 .
Conclusions
The field of epigenetics offers the promise of providing a context-dependent understanding of human healthspan. Improved knowledge of how epigenetic processes regulate ageing and how they interact with disease processes will enable the identification and stratification of patients at increased risk of age-related morbidities, including renal disease. Importantly, the ability to identify and track how environmental factors that influence health interact with individual cellular and molecular processes is critical to the identification and tailoring of precision interventions for diseases such as CKD.
Use of model organisms enables rapid and effective biological screening of therapeutic agents that target epigenetic processes. However, such studies provide only a first tier of assessment for human use. Longitudinal studies are required to assess the cross-generational stability and safety of novel therapies that target the age-related epigenetic landscape as well as their effects across the differing biological and psychosocial contexts of the life course. In addition, the human epigenetic landscape needs to be evaluated as a whole in concert with both genetic variation and epigenetic drift during natural ageing and in the presence of disease milieu, such as uraemia. Such a holistic approach is challenging given the heterogeneity and complexity of human ageing, but could have considerable benefits in enabling the identification of novel agents with the potential to improve age-related functional health.
